TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

high-throughput sequencing services

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published6
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: CELL THERAPY CATAPULT LIMITED: "high-throughput sequencing services". Published status: complete. Published value: Value not published. 6 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityCELL THERAPY CATAPULT LIMITEDScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: CELL THERAPY CATAPULT LIMITED
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for CELL THERAPY CATAPULT LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3.4Bids / Report
18.8% of reports have one bid
Supplier ConcentrationLow Concentration
HUBSPOT UK HOLDINGS LIMITEDTop vendor: 15.6% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 39 active published awards; 16 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
HUBSPOT UK HOLDINGS LIMITED1 win£221,800
Technopolis Limited2 wins£218,875
TECAN LIMITED1 win£160,193
GENEWIZ UK LIMITED3 wins£129,386
Digital Health & Care Innovation Centre (DHI) Contracted via University of Strathclyde1 win£92,000
Procedure terms
Contracting AuthorityCELL THERAPY CATAPULT LIMITED
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Dec 2025, 15:54 GMT
Last source update5 Dec 2025, 15:54 GMT
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-058ffe
What is being bought
The primary aim of this procurement is to secure a high-throughput sequencing service provider to perform sequencing services for the Cell and Gene Therapy (CGT) Catapult on a fee-per-service basis. This service will support the CGT Catapult's mission of accelerating the commercialization of innovation from research and overcoming technical barriers in advanced therapy medicinal product (ATMP) development. The selected provider's services will complement CGT Catapult's unique technical facilities and expertise at its London site. This procurement seeks comprehensive high-throughput sequencing services. These services will be utilized for deep process characterization, particularly for processes like stem cell differentiation and viral vector manufacturing. The required services include, but are not limited to: Lot 1 - High-throughput short-read sequencing of libraries generated by CGT Catapult (i.e., sequencing only) Lot 2 - Bulk RNA sequencing Lot 3 - Bulk small RNA sequencing Lot 4 - Single-cell RNA sequencing (scRNA-seq) of cryopreserved/fixed samples Lot 5 - AAV genome short-read sequencing Lot 6 - Sanger sequencing
What changed
From the official release history
  1. tender value changed
    5 Dec 2025, 15:54 GMT
  2. Status changed to complete
    5 Dec 2025, 15:54 GMT
  3. Official notice release published
    5 Dec 2025, 15:54 GMT
  4. Submission deadline changed to published date
    5 Dec 2025, 15:54 GMT
  5. tender value changed
    29 Aug 2025, 09:50 BST
  6. Status changed to active
    29 Aug 2025, 09:50 BST
  7. Official notice release published
    29 Aug 2025, 09:50 BST
  8. Submission deadline changed to 12 Sept 2025, 12:00 BST
    29 Aug 2025, 09:50 BST
  9. Buyer information updated
    29 Aug 2025, 09:50 BST
Lots and requirements (6)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 · #4
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 5 · #5
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 6 · #6
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Dec 2025, 15:54 GMT
  2. Award active
    5 Dec 2025, 00:00 GMT · £2,471
  3. Award active
    5 Dec 2025, 00:00 GMT · £126,725
  4. Award active
    5 Dec 2025, 00:00 GMT · £190
  5. Award active
    5 Dec 2025, 00:00 GMT · £6,000
  6. Award active
    5 Dec 2025, 00:00 GMT · £4,245
  7. Award active
    5 Dec 2025, 00:00 GMT · £5,088
Commercial outcome and competition
Awards
GENEWIZ UK LIMITED
£2,471 · 5 Dec 2025, 00:00 GMT · active
GENEWIZ UK LIMITED
£126,725 · 5 Dec 2025, 00:00 GMT · active
GENEWIZ UK LIMITED
£190 · 5 Dec 2025, 00:00 GMT · active
EDINBURGH GENETICS LIMITED
£6,000 · 5 Dec 2025, 00:00 GMT · active
Biomarker Technologies (BMK) GmbH
£4,245 · 5 Dec 2025, 00:00 GMT · active
NOVOGENE (UK) COMPANY LIMITED
£5,088 · 5 Dec 2025, 00:00 GMT · active
ContractsNo contract published
Bid statistics
bids: 6 (lot 1)
finalStageBids: 6 (lot 1)
smeFinalStageBids: 4 (lot 1)
vcseFinalStageBids: 0 (lot 1)
bids: 6 (lot 2)
finalStageBids: 6 (lot 2)
smeFinalStageBids: 4 (lot 2)
vcseFinalStageBids: 0 (lot 2)
bids: 5 (lot 3)
finalStageBids: 5 (lot 3)
smeFinalStageBids: 3 (lot 3)
vcseFinalStageBids: 0 (lot 3)
bids: 3 (lot 4)
finalStageBids: 3 (lot 4)
smeFinalStageBids: 2 (lot 4)
vcseFinalStageBids: 0 (lot 4)
bids: 2 (lot 5)
finalStageBids: 2 (lot 5)
smeFinalStageBids: 1 (lot 5)
vcseFinalStageBids: 0 (lot 5)
bids: 2 (lot 6)
finalStageBids: 2 (lot 6)
smeFinalStageBids: 1 (lot 6)
vcseFinalStageBids: 0 (lot 6)
Buyer and organisations in this procedure

CELL THERAPY CATAPULT LIMITED

Contracting authority GB-COH-07964711
View buyer profile
  • CELL THERAPY CATAPULT LIMITED
    buyer

    GB-COH: 07964711 · GB-PPON: PNLN-8116-PBCH
    12th Floor Tower Wing B, London, UKI44, SE1 9RT, GB
  • Biomarker Technologies (BMK) GmbH
    supplier

    19F13, Mereside C/O Logistics No. 21,, Alderley Park, UKD62, SK10 4TG, GB
  • EDINBURGH GENETICS LIMITED
    supplier

    GB-COH: SC650426 · GB-PPON: PYHR-1723-HVMX
    Pentlands Science Park, Penicuik, UKM73, EH26 0PZ, GB
  • GENEWIZ UK LIMITED
    supplier

    GB-COH: 09937828 · GB-PPON: PNYY-7229-LHCX
    Little Bullocks Farm, Hope End, Bishop's Stortford, UKH35, CM22 6TA, GB
  • NOVOGENE (UK) COMPANY LIMITED
    supplier

    GB-COH: 09353226 · GB-PPON: PWPB-6441-HXZL
    2nd Floor, Bio-Innovation Centre 25 Cambridge Science Park, Cambridge, UKH12, CB4 0FW, GB
Award and contract changes
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published